• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53在头颈部鳞状细胞癌中的免疫组化过表达:临床及预后意义

Immunohistochemical over expression of p53 in head and neck Squamous cell carcinoma: clinical and prognostic significance.

作者信息

Hashmi Atif Ali, Hussain Zubaida Fida, Hashmi Shumaila Kanwal, Irfan Muhammad, Khan Erum Yousuf, Faridi Naveen, Khan Amir, Edhi Muhammad Muzzammil

机构信息

Liaquat National Hospital and Medical College, Karachi, Pakistan.

CMH Multan Institute of Medical Sciences, Multan, Pakistan.

出版信息

BMC Res Notes. 2018 Jul 3;11(1):433. doi: 10.1186/s13104-018-3547-7.

DOI:10.1186/s13104-018-3547-7
PMID:29970180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6029369/
Abstract

OBJECTIVE

Immunohistochemical over expression of p53 is considered as a marker of poor prognosis in many cancers. Therefore, we aimed to evaluate immunohistochemical overexpression of p53 in 121 cases of head and neck Squamous cell carcinoma and its association with various clinicopathologic features and survival.

RESULTS

Total 66.1% (80 cases) expressed positive p53 expression, 34% (29 cases) revealed no p53 expression, while focal positive p53 expression was noted in 9.9% (12 Cases). Moreover, high p53 expression (> 70%) was noted in 26.4% (32 cases), while 19% (23 cases) showed 51-70% p53 expression. On the basis of intensity of p53 staining; strong p53 expression was noted in 39.7% (48 cases), while 24.8% (30 cases) and 10.7% (13 cases) revealed intermediate and weak p53 expression respectively. Significant association of p53 intensity of expression with extranodal extension and higher tumor grade (grades II and III) was noted. p53 is useful prognostic biomarker in head and neck Squamous cell carcinoma and therefore we suggest that more large scale studies are needed to evaluate its prognostic significance in our population.

摘要

目的

在许多癌症中,p53的免疫组化过表达被认为是预后不良的标志物。因此,我们旨在评估121例头颈部鳞状细胞癌中p53的免疫组化过表达情况及其与各种临床病理特征和生存率的关系。

结果

总计66.1%(80例)p53表达呈阳性,34%(29例)未检测到p53表达,而9.9%(12例)为局灶性p53阳性表达。此外,26.4%(32例)p53高表达(>70%),19%(23例)p53表达为51%-70%。根据p53染色强度;39.7%(48例)为强p53表达,24.8%(30例)和10.7%(13例)分别为中度和弱p53表达。p53表达强度与结外扩展及较高肿瘤分级(II级和III级)存在显著相关性。p53是头颈部鳞状细胞癌有用的预后生物标志物,因此我们建议需要更多大规模研究来评估其在我们人群中的预后意义。

相似文献

1
Immunohistochemical over expression of p53 in head and neck Squamous cell carcinoma: clinical and prognostic significance.p53在头颈部鳞状细胞癌中的免疫组化过表达:临床及预后意义
BMC Res Notes. 2018 Jul 3;11(1):433. doi: 10.1186/s13104-018-3547-7.
2
Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.南亚头颈部鳞状细胞癌中表皮生长因子受体(EGFR)的免疫组织化学表达:与各种风险因素及临床病理和预后参数的关系。
World J Surg Oncol. 2018 Jun 28;16(1):118. doi: 10.1186/s12957-018-1425-3.
3
p53 expression in concurrent chemoradiotherapy with docetaxel for head and neck squamous cell carcinoma.多西他赛同步放化疗治疗头颈部鳞状细胞癌时p53的表达
Auris Nasus Larynx. 2009 Feb;36(1):57-63. doi: 10.1016/j.anl.2008.02.002. Epub 2008 May 12.
4
Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.头颈部癌症的诊断与治疗及其与预后标志物表达的相关性研究。
Rom J Morphol Embryol. 2013;54(3):487-97.
5
Prognostic value of microvessel density and p53 expression on the locoregional metastasis and survival of the patients with head and neck squamous cell carcinoma.微血管密度和p53表达对头颈部鳞状细胞癌患者局部区域转移及生存的预后价值
Appl Immunohistochem Mol Morphol. 2013 Oct;21(5):444-51. doi: 10.1097/PAI.0b013e3182773125.
6
P53 overexpression in epidermoid carcinoma of the head and neck.头颈部表皮样癌中P53的过表达
Sao Paulo Med J. 1997 Jan-Feb;115(1):1349-55. doi: 10.1590/s1516-31801997000100006.
7
An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.一项评估p53和eIF4E癌症标志物在头颈部鳞状细胞癌(HNSCC)患者中的预后作用的澳大利亚回顾性研究:研究方案。
Asian Pac J Cancer Prev. 2013;14(8):4717-21. doi: 10.7314/apjcp.2013.14.8.4717.
8
Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中肿瘤抑制因子p53状态的分析。
Oncol Rep. 2004 Apr;11(4):923-9.
9
No prognostic significance of p53 expression in esophageal squamous cell carcinoma.p53表达在食管鳞状细胞癌中无预后意义。
J Surg Oncol. 1999 Oct;72(2):94-8. doi: 10.1002/(sici)1096-9098(199910)72:2<94::aid-jso10>3.0.co;2-9.
10
Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.细胞周期蛋白D1在头颈部鳞状细胞癌无瘤手术切缘中的表达的预后价值。
Acta Otolaryngol. 2013 Sep;133(9):984-91. doi: 10.3109/00016489.2013.795287. Epub 2013 May 22.

引用本文的文献

1
Field Cancerisation in Oral Squamous Cell Carcinoma Patients: A Systematic Review.口腔鳞状细胞癌患者的场癌化:一项系统综述
J Maxillofac Oral Surg. 2025 Apr;24(2):416-431. doi: 10.1007/s12663-024-02287-1. Epub 2024 Aug 7.
2
Correlating p53 immunostaining patterns with somatic TP53 mutation and functional properties of mutant p53 in triple-negative breast cancer.三阴乳腺癌中p53免疫染色模式与体细胞TP53突变及突变型p53功能特性的相关性
Histopathology. 2025 Aug;87(2):299-309. doi: 10.1111/his.15453. Epub 2025 Mar 31.
3
Immunoreactivity of LMO7 and other molecular markers as potential prognostic factors in oropharyngeal squamous cell carcinoma.LMO7 免疫反应性和其他分子标志物作为口咽鳞状细胞癌潜在的预后因素。
BMC Oral Health. 2024 Jun 25;24(1):729. doi: 10.1186/s12903-024-04510-4.
4
Gingival Carcinoma Cuniculatum: A Case Series of Seven Cases with Emphasis on Immunohistochemical and Histochemical Features.龈沟状癌:七例病例系列,重点关注免疫组织化学和组织化学特征
Indian J Otolaryngol Head Neck Surg. 2024 Jun;76(3):2930-2938. doi: 10.1007/s12070-024-04559-1. Epub 2024 Feb 19.
5
The Relationship of Grade, Stage and Tobacco Usage in Head and Neck Squamous Cell Carcinoma With p53, PIK3CA and MicroRNA Profiles.头颈部鳞状细胞癌中p53、PIK3CA和微小RNA谱与分级、分期及烟草使用的关系
Cureus. 2024 Feb 23;16(2):e54737. doi: 10.7759/cureus.54737. eCollection 2024 Feb.
6
p53, Cytokeratin 19 Expression in Oral Squamous Cell Carcinoma and Correlation with Histopathologic Grading: An Immunohistochemical Study.p53、细胞角蛋白19在口腔鳞状细胞癌中的表达及其与组织病理学分级的相关性:一项免疫组织化学研究
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):103-111. doi: 10.1007/s12070-023-04092-7. Epub 2023 Jul 26.
7
Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer.头颈癌当前及新出现的诊断、预后和预测生物标志物
Biomedicines. 2024 Feb 10;12(2):415. doi: 10.3390/biomedicines12020415.
8
Clinicopathological Parameters and Biomarker Profile in a Cohort of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).一组头颈部鳞状细胞癌(HNSCC)患者的临床病理参数和生物标志物谱
Cureus. 2023 Jul 15;15(7):e41941. doi: 10.7759/cureus.41941. eCollection 2023 Jul.
9
Clinicopathological Parameters Predicting Nodal Metastasis in Head and Neck Squamous Cell Carcinoma.预测头颈部鳞状细胞癌淋巴结转移的临床病理参数
Cureus. 2023 Jun 21;15(6):e40744. doi: 10.7759/cureus.40744. eCollection 2023 Jun.
10
Clinicopathologic characterization of cervical metastasis from an unknown primary tumor: a multicenter study in Korea.原发灶不明的颈部转移瘤的临床病理特征:韩国的一项多中心研究
J Pathol Transl Med. 2023 May;57(3):166-177. doi: 10.4132/jptm.2023.04.12. Epub 2023 May 10.

本文引用的文献

1
Changing Trends in oral cancer - a global scenario.口腔癌的变化趋势——全球概况
Nepal J Epidemiol. 2016 Dec 31;6(4):613-619. doi: 10.3126/nje.v6i4.17255. eCollection 2016 Dec.
2
Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis.口腔舌鳞状细胞癌的预后生物标志物:一项系统评价和荟萃分析。
Br J Cancer. 2017 Sep 5;117(6):856-866. doi: 10.1038/bjc.2017.244. Epub 2017 Jul 27.
3
Immunohistochemical expression of p53 and its clinicopathological correlation with modified Anneroth's histological grading system.p53的免疫组织化学表达及其与改良Anneroth组织学分级系统的临床病理相关性
J Oral Maxillofac Pathol. 2016 Jan-Apr;20(1):29-35. doi: 10.4103/0973-029X.180922.
4
Correlation between expressions of Cyclin-D1, EGFR and p53 with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.局部晚期口腔鳞状细胞癌患者中细胞周期蛋白D1、表皮生长因子受体和p53的表达与放化疗反应的相关性
BBA Clin. 2014 Nov 21;3:11-7. doi: 10.1016/j.bbacli.2014.11.004. eCollection 2015 Jun.
5
Status of p53 and p27(KIP1) in Iranian Patients With Oral Squamous Cell Carcinoma.伊朗口腔鳞状细胞癌患者中p53和p27(KIP1)的状况
Iran Red Crescent Med J. 2015 Oct 19;17(10):e19359. doi: 10.5812/ircmj.19359. eCollection 2015 Oct.
6
Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma.早期口腔鳞状细胞癌中细胞质和膜结合型 EGFR 及 p53 过表达是预后不良的标志物。
J Oral Pathol Med. 2012 Aug;41(7):559-67. doi: 10.1111/j.1600-0714.2012.01142.x. Epub 2012 Mar 14.
7
P53, p16 and Ki67 immunoexpression in oral squamous carcinomas.口腔鳞状细胞癌中P53、p16和Ki67的免疫表达
Rom J Morphol Embryol. 2012;53(1):89-93.
8
Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.口腔鳞状细胞癌和潜在恶性疾病中 p53、p16 和 hTERT 的免疫组织化学表达。
Braz Oral Res. 2011 Jan-Feb;25(1):34-41. doi: 10.1590/s1806-83242011000100007.
9
Global epidemiology of oral and oropharyngeal cancer.口腔和口咽癌的全球流行病学。
Oral Oncol. 2009 Apr-May;45(4-5):309-16. doi: 10.1016/j.oraloncology.2008.06.002. Epub 2008 Sep 18.
10
Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.p53及血管生成在口腔良性和癌前病变与口腔鳞状细胞癌中的免疫组织化学研究
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103(3):385-90. doi: 10.1016/j.tripleo.2005.11.008. Epub 2006 Jun 30.